HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

9-amino-20-camptothecin

induces regression of human ovarian carcinomas grown in mice & distinguishes between non-tumorigenic & tumorigenic cells in vitro; RN given refers to (S)-isomer; RN for cpd without isomeric designation not avail 4/93
Also Known As:
9-amino-20(S)-camptothecin; 9-amino-20-camptothecin, (+-)-isomer; 9-amino-CPT; 9-aminocamptothecin; NSC 603071
Networked: 64 relevant articles (7 outcomes, 30 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Zamboni, William C: 3 articles (08/2008 - 07/2005)
2. Strychor, Sandra: 3 articles (08/2008 - 07/2005)
3. Egorin, Merrill J: 3 articles (08/2008 - 07/2005)
4. Eiseman, Julie L: 2 articles (08/2008 - 07/2005)
5. Joseph, Erin: 2 articles (08/2008 - 07/2005)
6. Parise, Robert A: 2 articles (08/2008 - 05/2006)
7. Prijovich, Zeljko M: 2 articles (06/2007 - 10/2003)
8. Roffler, Steve R: 2 articles (06/2007 - 10/2003)
9. Leu, Yu-Lin: 2 articles (06/2007 - 10/2003)
10. Chen, B-M: 2 articles (02/2007 - 05/2002)

Related Diseases

1. Neoplasms (Cancer)
2. Leukemia
3. Glioblastoma (Glioblastoma Multiforme)
4. Neoplasm Metastasis (Metastasis)
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. Type I DNA Topoisomerases (Topoisomerase I)
2. irinotecan (Camptosar)
3. Topotecan (Hycamtin)
4. Glucuronidase
5. Prodrugs
6. Aniline Mustard
7. 9-aminocamptothecin glucuronide
8. CD80 Antigens
9. lurtotecan
10. aniline (aniline hydrobromide)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Intravenous Infusions
3. Oral Administration